Literature DB >> 16083965

Receptor systems: will mining the receptorome yield novel targets for pharmacotherapy?

Bryan L Roth1.   

Abstract

We have recently defined the receptorome as 'that part of the proteome encoding receptors'. In this article, I provide a general overview of the members of the receptorome as well as methods used to screen the receptorome-both in silico and physically. Case histories of receptorome-based discovery efforts are then highlighted and the relevance of this approach to the discovery and validation of molecular targets for drug abuse treatment is emphasized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083965     DOI: 10.1016/j.pharmthera.2005.06.013

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  6 in total

Review 1.  Challenges and opportunities for new protein crystallization strategies in structure-based drug design.

Authors:  Jessica Lynn Grey; David H Thompson
Journal:  Expert Opin Drug Discov       Date:  2010-11       Impact factor: 6.098

2.  Structure-based discovery of beta2-adrenergic receptor ligands.

Authors:  Peter Kolb; Daniel M Rosenbaum; John J Irwin; Juan José Fung; Brian K Kobilka; Brian K Shoichet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

3.  Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Authors:  Roy Moncayo
Journal:  EJNMMI Res       Date:  2011-07-26       Impact factor: 3.138

Review 4.  Large-scale production and protein engineering of G protein-coupled receptors for structural studies.

Authors:  Dalibor Milić; Dmitry B Veprintsev
Journal:  Front Pharmacol       Date:  2015-03-31       Impact factor: 5.810

5.  Covering complete proteomes with X-ray structures: a current snapshot.

Authors:  Marcin J Mizianty; Xiao Fan; Jing Yan; Eric Chalmers; Christopher Woloschuk; Andrzej Joachimiak; Lukasz Kurgan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-10-23

Review 6.  Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.

Authors:  Hyeong-Min Lee; Yuna Kim
Journal:  Schizophr Res Treatment       Date:  2016-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.